TY - JOUR
T1 - Influence of fulvic acid and hydroxy propyl-β-cyclodextrin on aspirin degradation
AU - Anwer, Mohammad Khalid
AU - Agarwal, Suraj Prakash
AU - Ali, Asgar
AU - Sultana, Yasmin
PY - 2010/4
Y1 - 2010/4
N2 - Objective: The degradation of aspirin (ASA) was investigated to reveal information about the influence of complexation with fulvic acid (FA), as a new complexing agent and compared with hydroxy propyl-β-cyclodextrin complex. Materials and methods: ASA was complexed with FA in the molar ratio 1:0.5, 1:1, and 1:2 by different methods through lyophilization, solvent evaporation, and spray drying. Spray-dried (1:1) ASAhydroxy propyl-β-cyclodextrin complex was prepared and compared with optimized complex of FA. All the complexes and ASA alone were packaged in well-labeled sealed polythene-lined aluminum pouches and stored in stability chamber at 40 ± 2°C and 75 ± 5% relative humidity for 120 days. Samples were analyzed for salicylic acid content at 0, 30, 60, 90, and 120 days. Results: Overall 4.31 salicylic acid was formed in 1:1 ASAFA spray-dried complex, which was optimized stable complex among other complexes of FA prepared by different methods in different molar ratios. However, 2.35% salicylic acid was measured with 1:1 spray-dried ASAhydroxy propyl-β-cyclodextrin complex. Stability of ASA increased more when complexed with hydroxy propyl-β-cyclodextrin as compared to FA. Conclusions: A novel complexing agent in the form of FA was investigated to increase the stability of ASA. A marked improvement in stability of ASA was observed when complexed with hydroxy propyl-β-cyclodextrin (1:1) by spray drying as compared to 1:1 spray-dried ASAFA complex.
AB - Objective: The degradation of aspirin (ASA) was investigated to reveal information about the influence of complexation with fulvic acid (FA), as a new complexing agent and compared with hydroxy propyl-β-cyclodextrin complex. Materials and methods: ASA was complexed with FA in the molar ratio 1:0.5, 1:1, and 1:2 by different methods through lyophilization, solvent evaporation, and spray drying. Spray-dried (1:1) ASAhydroxy propyl-β-cyclodextrin complex was prepared and compared with optimized complex of FA. All the complexes and ASA alone were packaged in well-labeled sealed polythene-lined aluminum pouches and stored in stability chamber at 40 ± 2°C and 75 ± 5% relative humidity for 120 days. Samples were analyzed for salicylic acid content at 0, 30, 60, 90, and 120 days. Results: Overall 4.31 salicylic acid was formed in 1:1 ASAFA spray-dried complex, which was optimized stable complex among other complexes of FA prepared by different methods in different molar ratios. However, 2.35% salicylic acid was measured with 1:1 spray-dried ASAhydroxy propyl-β-cyclodextrin complex. Stability of ASA increased more when complexed with hydroxy propyl-β-cyclodextrin as compared to FA. Conclusions: A novel complexing agent in the form of FA was investigated to increase the stability of ASA. A marked improvement in stability of ASA was observed when complexed with hydroxy propyl-β-cyclodextrin (1:1) by spray drying as compared to 1:1 spray-dried ASAFA complex.
KW - Aspirin
KW - Complexation
KW - Fulvic acid
KW - Hydroxy propyl-b-cyclodextrin
KW - Shilajit
KW - Stability
UR - https://www.scopus.com/pages/publications/77749295759
U2 - 10.3109/03639040903225091
DO - 10.3109/03639040903225091
M3 - Article
C2 - 19740038
AN - SCOPUS:77749295759
SN - 0363-9045
VL - 36
SP - 428
EP - 430
JO - Drug Development and Industrial Pharmacy
JF - Drug Development and Industrial Pharmacy
IS - 4
ER -